Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome?
Jacobi
U
U
Waibler
E
E
Schulze
P
P
Sehouli
J
J
Oskay-Ozcelik
G
G
Schmook
T
T
Sterry
W
W
Lademann
J
J
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000032:analysis*; D004317:Doxorubicin / Q000032:analysis* / Q000037:antagonists & inhibitors; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012871:Skin Diseases / Q000139:chemically induced*; D013542:Sweat / Q000737:chemistry*
D000970:Antineoplastic Agents; D004317:Doxorubicin